scispace - formally typeset
M

Marie Piette

Researcher at University of Liège

Publications -  13
Citations -  322

Marie Piette is an academic researcher from University of Liège. The author has contributed to research in topics: Liposome & Cyclodextrin. The author has an hindex of 7, co-authored 13 publications receiving 299 citations. Previous affiliations of Marie Piette include Université libre de Bruxelles.

Papers
More filters
Journal ArticleDOI

Betamethasone-in-cyclodextrin-in-liposome: The effect of cyclodextrins on encapsulation efficiency and release kinetics

TL;DR: It is shown that release kinetics are directly correlated with encapsulation efficiency, which is closely related to betamethasone concentration in cyclodextrin complex solution, which was proved by the comparison of phase solubility diagrams of both betamETHasone and cholesterol.
Journal ArticleDOI

Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives.

TL;DR: Benfotiamine, an S-acyl derivative practically insoluble in organic solvents, should be differentiated from truly lipid-soluble thiamine disulfide derivatives with a different mechanism of absorption and different pharmacological properties, which would explain why beneficial effects of benfutiamine have only been observed in peripheral tissues.
Journal ArticleDOI

Study of the relationship between lipid binding properties of cyclodextrins and their effect on the integrity of liposomes.

TL;DR: It was shown that the observed effect on calcein release can be directly related to the affinity of cyclodextrins for both lipid components of liposomes, cholesterol and phosphatidylcholine.
Journal ArticleDOI

Mucoadhesive cellulosic derivative sponges as drug delivery system for vaginal application

TL;DR: The aim of this study was to formulate and to characterize a solid system, called sponges, obtained by lyophilization of cellulosic derivative (HEC 250M) hydrogels, considered as potential drug delivery systems intended for vaginal application.
Journal ArticleDOI

Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28-2653) after IV and oral administration of cyclodextrin solutions.

TL;DR: An increase in Ro 28-2653 solubility, via ternary complex formation, can lead to an increase in the oral bioavailability of this drug, and a synergistic effect exists between hydroxypropyl-beta-cyclodextrin (HP- beta-CD) and l-lysine.